For patient selection, m5C/NSUN6–NDRG1 signatures predicted radioresistance in cervical cancer organoids/clinical cohorts, recommending pathway readouts as prospective biomarkers alongside m6A-DDR/ferroptosis panels (140) (Table 2). This evidence concerns the gene NDRG1 and cervical carcinoma.